Georgia · Q5106

Injection, Epoetin Alfa-Epbx, Biosimilar, (retacrit) (for Non-Esrd Use), 1000 Units in Georgia

Georgia Medicare Avg
$6.04
0% below national avg
National Medicare Avg
$6.07
All states combined
Billed Charge (GA)
$33.89
What providers submit
Est. Commercial (GA)
$17.42
National avg: $17.32
Est. Cash / Self-Pay (GA)
$15.13
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

31.3K
Services in GA
67
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Georgia

Provider Medicare Services
Vyas, Harsha M.D., $6.28 11.3K

Georgia Pricing in Context

In Georgia, CPT code Q5106 (Injection, Epoetin Alfa-Epbx, Biosimilar, (retacrit) (for Non-Esrd Use), 1000 Units) carries an average Medicare payment of $6.04 — 0% below the national benchmark of $6.07. 67 providers across the state submitted claims for this procedure in 2023, performing 31.3K total services. Individual payments in GA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Georgia is $33.89, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Georgia sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Temporary Codes procedures, the estimated commercial insurance price in Georgia lands near $17.42, with self-pay cash prices typically around $15.13. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Injection, Epoetin Alfa-Epbx, Biosimilar, (retacrit) (for Non-Esrd Use), 1000 Units cost in Georgia?

The average Medicare payment for Injection, Epoetin Alfa-Epbx, Biosimilar, (retacrit) (for Non-Esrd Use), 1000 Units in Georgia is $6.04, which is 0% below the national average of $6.07. Providers in GA typically bill $33.89 for this procedure.

What does Injection, Epoetin Alfa-Epbx, Biosimilar, (retacrit) (for Non-Esrd Use), 1000 Units cost with insurance in Georgia?

With commercial insurance in Georgia, Injection, Epoetin Alfa-Epbx, Biosimilar, (retacrit) (for Non-Esrd Use), 1000 Units costs an estimated $17.42. Without insurance, the estimated cash price is $15.13. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Injection, Epoetin Alfa-Epbx, Biosimilar, (retacrit) (for Non-Esrd Use), 1000 Units in Georgia?

67 providers in Georgia billed Medicare for Injection, Epoetin Alfa-Epbx, Biosimilar, (retacrit) (for Non-Esrd Use), 1000 Units in 2023, performing 31.3K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Injection, Epoetin Alfa-Epbx, Biosimilar, (retacrit) (for Non-Esrd Use), 1000 Units cheaper in Georgia than the national average?

Yes — Injection, Epoetin Alfa-Epbx, Biosimilar, (retacrit) (for Non-Esrd Use), 1000 Units costs 0% below the national average in Georgia. The state average Medicare payment is $6.04 compared to $6.07 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial